Therapies targeting CTSK (such as inhibitors) show promise but raise safety concerns including off-target effects and increased stroke risk.<h4>Conclusion</h4>CTSK is a central hub integrating upstream signals to regulate systemic ECM homeostasis, making it a promising therapeutic target. Here, CTSK is linked to Stroke.